http://www.zibb.com/healthcare/theme/cq/BioVeris+Corporation Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 04 Apr 2007 00:00:00 GMTWed, 04 Apr 2007 00:00:00 GMT608831http://www.zibb.com/healthcare/theme/cq/BioVeris+Corporation http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.genengnews.com/news/bnitem.aspx?name=15248881Roche is expanding its immunochemistry business through a $600-million acquisition of BioVeris. This transaction comes less than a week after the company reported plans to take ovehttp://www.genengnews.com/news/bnitem.aspx?name=15248881BioVeris CorporationWed, 04 Apr 2007 00:00:00 GMThttp://www.newsrx.com/newsletters/Vaccine-Weekly/2007-01-24/420124200715VW.htmlThese new combination vaccines are expected to have the advantage of reducing the number of injections that a child would receive during a single office visit. ...http://www.newsrx.com/newsletters/Vaccine-Weekly/2007-01-24/420124200715VW.htmlBioVeris Corporationhttp://www.newsrx.com/newsletters/Vaccine-Weekly/2007-02-21/420221200714VW.htmlBioVeris received an exclusive, worldwide license to certain patent rights and know-how to use Neisseria meningitidis group Y and Haemophilus influenzae type b A bacterial infection that may result in severe respiratory infections, including pneumonia, and other diseases such as meningitis.http://www.newsrx.com/newsletters/Vaccine-Weekly/2007-02-21/420221200714VW.htmlBioVeris Corporation